 |
|
Delayed-Onset Hypothesis of Antipsychotic Action
A Hypothesis Tested and Rejected
Ofer Agid, MD;
Shitij Kapur, MD, PhD, FRCPC;
Tamara Arenovich, MSc;
Robert B. Zipursky, MD, FRCPC
Arch Gen Psychiatry. 2003;60:1228-1235.
Context To understand the mechanism of action of antipsychotic drugs, it is critical to recognize the time course over which these medications take effect. Current models of antipsychotic action presume a "delayed onset" of action.
Objective To test the delayed-onset hypothesis of antipsychotic action via a meta-analytic study.
Data Sources and Study Selection Double-masked studies that reported results from active or placebo-controlled trials of antipsychotic response during the first 4 weeks of treatment were selected. These studies were identified by searching MEDLINE, 1996 to 2001; the Cumulative Index to Nursing and Allied Health, 1982 to 2001; EMBASE, 1980 to 2001; the ACP Journal Club; the Cochrane Database of Systematic Reviews; and the Database of Abstracts of Reviews of Effectiveness. Leads from these sources were followed up by manual searches.
Data Synthesis Forty-two published studies, including 7450 patients and 119 independent response vs time curves, were identified. Reductions in total scores on the Brief Psychiatric Rating Scale and the Positive and Negative Syndrome Scale were 13.8% during week 1, 8.1% during week 2, 4.2% during week 3, and 4.7% during week 4. This pattern of "early-onset" improvement was present even after the estimated effect of placebo treatment was removed and when results were restricted to the psychotic subscales of the scales.
Conclusions This analysis rejects the commonly held hypothesis that antipsychotic response is delayed. Rather, these findings suggest that the antipsychotic response starts in the first week of treatment and accumulates over time. Furthermore, greater improvement occurs in the first 2 treatment weeks than in the subsequent 2 treatment weeks. Proposed mechanisms of action of antipsychotic drugs need to account for this early-onset antipsychotic effect.
From the Schizophrenia Program (Drs Agid, Kapur, and Zipursky) and the PET Centre (Drs Agid and Kapur), Centre for Addiction and Mental Health, and the Departments of Psychiatry (Drs Agid, Kapur, and Zipursky) and Statistics (Ms Arenovich), University of Toronto, Toronto, Ontario.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia
Canuso et al.
Am. J. Psychiatry 2009;166:691-701.
ABSTRACT
| FULL TEXT
The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
Fatemi and Folsom
Schizophr Bull 2009;35:528-548.
ABSTRACT
| FULL TEXT
What We Know: Findings That Every Theory of Schizophrenia Should Explain
MacDonald and Schulz
Schizophr Bull 2009;35:493-508.
ABSTRACT
| FULL TEXT
Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia
Ascher-Svanum et al.
Schizophr Bull 2008;34:1163-1171.
ABSTRACT
| FULL TEXT
Trajectories and Antecedents of Treatment Response Over Time in Early-Episode Psychosis
Levine and Rabinowitz
Schizophr Bull 2008;0:sbn120v1-sbn120.
ABSTRACT
| FULL TEXT
Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT--PCR study
Robbins et al.
J Psychopharmacol 2008;22:536-542.
ABSTRACT
Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research
McMahon et al.
Schizophr Bull 2008;34:292-301.
ABSTRACT
| FULL TEXT
Unanswered Questions in Schizophrenia Clinical Trials
Kane and Leucht
Schizophr Bull 2008;34:302-309.
FULL TEXT
Reduction in Salivary Cortisol Concentration Correlates with Resolution of Psychosis in Cushing's Syndrome
Myhill et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:113-115.
FULL TEXT
Author's reply
Mitchell
Br. J. Psychiatry 2006;188:587-587.
FULL TEXT
Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia
Emsley et al.
Am. J. Psychiatry 2006;163:743-745.
ABSTRACT
| FULL TEXT
Intramuscular haloperidol and olanzapine begin to reduce psychosis within 24 hours
Leucht and Davis
Evid. Based Ment. Health 2006;9:9-9.
FULL TEXT
A growing evidence base for management guidelines: REVISITING... GUIDELINES FOR THE MANAGEMENT OF ACUTELY DISTURBED PSYCHIATRIC PATIENTS
Macpherson et al.
Adv. Psychiatr. Treat. 2005;11:404-415.
ABSTRACT
| FULL TEXT
Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment
Kapur et al.
Am. J. Psychiatry 2005;162:939-946.
ABSTRACT
| FULL TEXT
|
